Bmtcn test questions Study guides, Class notes & Summaries

A patient developed type 4 PTLD three years after an allogeneic HSCT. Which of the following treatment interventions would the nurse expect an order for? - ANSWER-Aggressive chemotherapy Red bone marrow produces - ANSWER-hematopoietic stems cells that create red blood cells, white blood cells and platelets and is found in the long and flat bones yellow bone marrow and fat cells produce - ANSWER-stromal stem cells that produce fat, cartilage and bone and are found in the long bones. hemato...

A patient developed type 4 PTLD three years after an allogeneic HSCT. Which of the following treatment interventions would the nurse expect an order for? - ANSWER-Aggressive chemotherapy Red bone marrow produces - ANSWER-hematopoietic stems cells that create red blood cells, white blood cells and platelets and is found in the long and flat bones yellow bone marrow and fat cells produce - ANSWER-stromal stem cells that produce fat, cartilage and bone and are found in the long bones. hemato...

A patient developed type 4 PTLD three years after an allogeneic HSCT. Which of the following treatment interventions would the nurse expect an order for? - ANSWER-Aggressive chemotherapy Red bone marrow produces - ANSWER-hematopoietic stems cells that create red blood cells, white blood cells and platelets and is found in the long and flat bones yellow bone marrow and fat cells produce - ANSWER-stromal stem cells that produce fat, cartilage and bone and are found in the long bones. hemato...

BMTCN TEST QUESTIONS WITH CORRECT ANSWERS.

BMTCN TEST QUESTIONS AND ANSWERS

BMTCN Test Which of the following is NOT an identified risk factor associated with infection? A. Personal history of infection B. Type of transplantation (autologous or allogeneic) C. Myeloablative Transplant D. None of the Above - correct answer D. None of the above Clostridium difficile is not a common infection in the post-transplant setting A. True B. False - correct answer B. False A cord blood transplantation is associated with all of the following except: A. Prolonged neutr...

BMTCN Test Questions With 100% Correct Answers

What type of transplants commonly have PTLD as a secondary malignancy? Allo HSCT with T-cell depleted graft Therapies associated with therapy-related acute leukemia and MDS alkylating agents (eg. Cytoxan, cisplatin, melphalan, busulfan, ifos) , radiation, topoisomerase II inhibitors (eg. doxorubicin, etoposide, mitoxantrone) Genetic predispositions that increase risk of primary and secondary cancers neurofibromatosis type 1, Fanconi anemia Risk factors for PTLD T-cell de...

BMTCN TEST QUESTIONS WITH CORRECT ANSWERS